Skip Navigation


Carcinogenesis Advance Access originally published online on April 29, 2004
Carcinogenesis 2004 25(9):1701-1709; doi:10.1093/carcin/bgh179
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
25/9/1701    most recent
bgh179v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Srivastava, S. K.
Right arrow Articles by Singh, S. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Srivastava, S. K.
Right arrow Articles by Singh, S. V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis vol.25 no.9 © Oxford University Press 2004; all rights reserved.

ARTICLE

Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells

Sanjay K. Srivastava1 and Shivendra V. Singh

Department of Pharmacology and University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

1 To whom correspondence should be addressed Email: srivastavask{at}msx.upmc.edu

Benzyl isothiocyanate (BITC), a cruciferous vegetable-derived compound, has been shown to inhibit chemically induced cancer in animal models. Moreover, epidemiological studies have provided compelling evidence to suggest that cruciferous vegetables may be protective against cancer risk. Here, we report that BITC significantly inhibits growth of human pancreatic cancer BxPC-3 cells in a concentration-dependent manner with an IC50 of ~8 µM, a concentration that can be generated through dietary intake of cruciferous vegetables. Treatment of BxPC-3 cells with growth suppressive concentrations of BITC resulted in G2/M phase cell cycle arrest that was associated with a marked decline in protein levels of G2/M regulatory proteins including cyclin-dependent kinase 1 (Cdk1), cyclin B1 and cell division cycle 25B (Cdc25B). Further, BITC-mediated growth inhibition of BxPC-3 cells correlated with apoptosis induction that was characterized by an increase in Bax/Bcl-2 ratio, cleavage of procaspase-3 and poly(ADP-ribose)polymerase (PARP), and an increase in cytoplasmic histone-associated DNA fragmentation. Interestingly, BITC treatment caused inhibition of nuclear factor {kappa}B (NF-{kappa}B) activation, which is constitutively activated in human pancreatic cancer. Western blotting revealed concentration-dependent decrease in NF-{kappa}B/Rel-p65 protein level in BxPC-3 cells upon exposure to BITC. An increase in protein level of inhibitory subunit {kappa}B (I{kappa}Ba) in association with reduced serine-32 phosphorylation was also observed in BITC-treated BxPC-3 cells. Consistent with these findings, BITC treatment caused a decrease in nuclear translocation of NF-{kappa}B as reflected by reduced DNA-binding capacity of NF-{kappa}B. Furthermore, the protein level of cyclin D1, a transcriptional target of NF-{kappa}B, was reduced significantly in BITC-treated BxPC-3 cells. To the best of our knowledge, this study is the first published report to implicate suppression of NF-{kappa}B activation as a potential mechanism for anti-proliferative activity of BITC against human pancreatic cancer cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
R. P. Sahu and S. K. Srivastava
The Role of STAT-3 in the Induction of Apoptosis in Pancreatic Cancer Cells by Benzyl Isothiocyanate
J Natl Cancer Inst, February 4, 2009; 101(3): 176 - 193.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Xiao, A. A. Powolny, and S. V. Singh
Benzyl Isothiocyanate Targets Mitochondrial Respiratory Chain to Trigger Reactive Oxygen Species-dependent Apoptosis in Human Breast Cancer Cells
J. Biol. Chem., October 31, 2008; 283(44): 30151 - 30163.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
F. Liotta, R. Angeli, L. Cosmi, L. Fili, C. Manuelli, F. Frosali, B. Mazzinghi, L. Maggi, A. Pasini, V. Lisi, et al.
Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch Signaling
Stem Cells, January 1, 2008; 26(1): 279 - 289.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Xiao and S. V. Singh
Phenethyl Isothiocyanate Inhibits Angiogenesis In vitro and Ex vivo
Cancer Res., March 1, 2007; 67(5): 2239 - 2246.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
N. M. Probst-Hensch, C.-L. Sun, D. V. D. Berg, M. Ceschi, W.-P. Koh, and M. C. Yu
The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study
Carcinogenesis, December 1, 2006; 27(12): 2475 - 2482.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
H. Hwa Cho, Y. C. Bae, and J. S. Jung
Role of Toll-Like Receptors on Human Adipose-Derived Stromal Cells
Stem Cells, December 1, 2006; 24(12): 2744 - 2752.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
D. Xiao, V. Vogel, and S. V. Singh
Benzyl isothiocyanate-induced apoptosis in human breast cancer cells is initiated by reactive oxygen species and regulated by Bax and Bak.
Mol. Cancer Ther., November 1, 2006; 5(11): 2931 - 2945.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Xiao, K. L. Lew, Y. Zeng, H. Xiao, S. W. Marynowski, R. Dhir, and S. V. Singh
Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential
Carcinogenesis, November 1, 2006; 27(11): 2223 - 2234.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Zhang, S. Loganathan, I. Humphreys, and S. K. Srivastava
Benzyl Isothiocyanate-Induced DNA Damage Causes G2/M Cell Cycle Arrest and Apoptosis in Human Pancreatic Cancer Cells
J. Nutr., November 1, 2006; 136(11): 2728 - 2734.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. C. Larsson, N. Hakansson, I. Naslund, L. Bergkvist, and A. Wolk
Fruit and vegetable consumption in relation to pancreatic cancer risk: a prospective study.
Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 301 - 305.
[Abstract] [Full Text] [PDF]


Home page
ANN BOT (LOND)Home page
J. W. FINLEY
Proposed Criteria for Assessing the Efficacy of Cancer Reduction by Plant Foods Enriched in Carotenoids, Glucosinolates, Polyphenols and Selenocompounds
Ann. Bot., June 1, 2005; 95(7): 1075 - 1096.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. A. Hasan, G. Trinchieri, and J. Vlach
Toll-like Receptor Signaling Stimulates Cell Cycle Entry and Progression in Fibroblasts
J. Biol. Chem., May 27, 2005; 280(21): 20620 - 20627.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Xiao, Y. Zeng, S. Choi, K. L. Lew, J. B. Nelson, and S. V. Singh
Caspase-Dependent Apoptosis Induction by Phenethyl Isothiocyanate, a Cruciferous Vegetable-Derived Cancer Chemopreventive Agent, Is Mediated by Bak and Bax
Clin. Cancer Res., April 1, 2005; 11(7): 2670 - 2679.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.